Alnylam Pharmaceuticals Provides Perspective on Positive Complete Results from ORION-11 Phase 3 Study of Inclisiran

Alnylam Pharmaceuticals Provides Perspective on Positive Complete Results from ORION-11 Phase 3 Study of Inclisiran

CAR-T Therapy Development on the Rise

CAR-T Therapy Development on the Rise

5 Biopharma Trends to Watch in 2019

5 Biopharma Trends to Watch in 2019